Nectar Lifesciences Limited -1.79 % Drug Manufacturers - Major

Trend Analysis

Loading...

Support and Resistance Levels Analysis
The current close value 19.2 is between the support and resistance channel of 19 and 22. The stock has a Sell Signal , 19 becomes a critical support to stop the fall and 22 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 19.8
MACD value -0.8
Price range 19.15 to 28.75
Volume range 94456 to 324588
Support & Resistance 19, 22
Stock Performance
Six Months -16.7%
Five Months-4.0%
Four Months-16.9%
Three Months-31.1%
Two Months-14.1%
One Month-18.0%
Last Six Months

-16.7%

Last Five Months

-4.0%

Last Four Months

-16.9%

Last Three Months

-31.1%

Last Two Months

-14.1%

Last One Month

-18.0%

Analysis
Volume
Today's Price Range
3 Month Price Range
About Nectar Lifesciences Limited
Nectar Lifesciences Limited (Neclife) is an India-based pharmaceutical company. The Company's business activities include Contract Research and Manufacturing Services, APIs and Intermediates, Formulations, Generics and Over-The-Counter (OTC), Diagnostics, Hard Gelatin Capsules and Menthol. The Company's is focused on manufacturing and marketing of oral and sterile cephalosporin intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It also manufactures capsules and natural menthol. The Company offers contract manufacturing services for products from development through to bulk production and In-Vitro Diagnostics. Some of the services offered the Company include Process development and optimization, Process scale up and validation, Preparation and submission of Drug Master Files, among others.
See stocks similar to Nectar Lifesciences Limited in Drug Manufacturers - Major

Nectar Lifesciences Limited has Sell Signal. What is your opinion on it?

{ }